Rolf Swenson, PhD
Dr. Swenson has over 20 years of experience in the pharmaceutical industry directing discovery research in different capacities. He contributed to programs in a large pharmaceutical company (Abbott Laboratories), a biotechnology company (Orchid Biosciences) from pre-IPO to post-IPO, and a private international imaging company (Bracco Diagnostics). He managed research groups focused on the discovery of new imaging and therapeutic agents, and on the development of novel devices that use microfluidic technology for genomic applications.
Dr. Swenson has over 34 publications in peer-reviewed journals and is an inventor on 43 US patents and 8 pending patent applications. His patented work includes a process to prepare the approved drug Zemplar (paricalcitol), and four therapeutic compounds and one diagnostic compound that have reached the clinic to treat or image cancer.
Dr. Swenson’s BA is in Chemistry, with minors in mathematics and economics from University of California San Diego, and his PhD is in Organic Chemistry from Cornell University.
Donna J Piper, MBA
Chief Business Officer
Ms Piper received her MBA from Boston University. She has a BS in Biology and Chemistry. She has worked at Wyeth, Johnson and Johnson, Forest Laboratories and Bracco Diagnostics. Prior to entering industry, she managed a research and clinical laboratory at the University of California, San Francisco. She also worked at Massachusetts General Hospital and the Gladstone Institute. Ms. Piper is published in endocrinology, biochemistry and microbiology in various journals. She has been a member of the Licensing Executive Society since 1989.